ArticleMedicine2026
Sociodemographic correlates of human papilloma virus (HPV) and cervical cancer knowledge among Saudi women: A nationwide assessment.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human papilloma virus (HPV) is one of the most frequent sexually transmitted viruses globally, with serious clinical consequences, such as cervical cancer. This study aims to evaluate knowledge and awareness of, and attitudes and beliefs towards, HPV and vaccines for it among women from several Saudi Arabian regions. A cross-sectional descriptive study was carried out among Saudi Arabian women. Data were collected from December 9, 2024, to May 9, 2025, via an online survey including women's demographics, knowledge, awareness, attitudes, and beliefs regarding HPV and vaccination against it. An overall of 627 women took part in the study. The majority of the population (32.1%) is aged from 36 to 45 years. In total, 47.4% of the participants have an adequate level of knowledge of HPV, 51.5% know that it is sexually transmitted, and 41.3% know that it can cause cervical cancer. The main information sources were the Ministry of Health and social media. Around 66.7% of the participants believed that the HPV vaccine is not safe. Marital status, religion, and educational status were demonstrably associated with overall knowledge and awareness of HPV and a vaccine for it. Age, marital status, children, region, education level, and occupation were significantly associated with beliefs concerning HPV. This study reported a gap in awareness and knowledge of cervical cancer and HPV; risk and HPV vaccination complications were found to be barriers to vaccine acceptance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.